Objectives: Matrix metallopeptidase-7 (MMP-7) and osteopontin (OPN) are important
components in the pathophysiology of fibrosis in biliary atresia (BA). There has been much …

Background: Differentiation of neonatal cholestasis into neonatal hepatitis (NH) and
extrahepatic biliary atresia (EHBA) is essential to formulate the treatment plan; promptness …

Objective To assess the diagnostic and prognostic usefulness of the serum matrix
metallopeptidase-7 (MMP-7) level for biliary atresia in infants with cholestasis after …

Background Biliary atresia (BA) is among the commonest indications for liver transplantation
(LT) in children. We examined whether serum matrix metalloproteinase‐7 (MMP‐7) is useful …

Purpose We aimed to assess the dynamic changing trend of serum matrix metalloproteinase-
7 (MMP-7) in biliary atresia (BA) patients from diagnosis to LTx to further elucidate its clinical …

Conclusions: Serum MMP-7 has high discriminative properties to differentiate BA from other
forms of neonatal cholestasis. MMP-7 cutoff values vary according to assay technology …

Background The aim of this study was to evaluate the serum level of matrix
metalloproteinase 7 (MMP7) in infants with cholestasis and the diagnostic values of this …

Background Matrix metalloproteinase 7 (MMP7) has been suggested as a promising
biomarker in diagnosing biliary atresia (BA). This study aimed to assess the diagnostic …

Biliary atresia (BA) is a severe cholestatic liver disease in children featuring cholestasis and
liver fibrosis. The early diagnosis of BA is still challenging. This study aimed to evaluate the …

BACKGROUND: The overlapping features of biliary atresia (BA) and other neonatal
cholestasis with alternative causes (non-BA) have posed challenges for diagnosis. Matrix …